Liminatus Pharma, Inc. Class A Common Stock
$3.04
-0.17 (-5.30%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -10.3%
- 3 Months
- -46.7%
- YTD
- -90.0%
- 1 Year
- -95.0%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 4488.1%
- Largest decline max drawdown, since May 2025
- -100.0%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.95
Own LIMN?
See how LIMN contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.